Jianyu Nie

Hefei, 230022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ruthenium-gallic acid nanozymes encapsulated in 3D bioprintable photosensitive hydrogels for synergistic PTT/CDT therapy of glioblastoma.

Ruthenium-gallic acid nanozymes encapsulated in 3D bioprintable photosensitive hydrogels for synergistic PTT/CDT therapy of glioblastoma.

Journal: Journal of nanobiotechnology

Published: February 11, 2026

Multidrug resistance in cancer: current understandings and future perspective.

Multidrug resistance in cancer: current understandings and future perspective.

Journal: Molecular biomedicine

Published: September 08, 2025

Effects of Pneumocephalus on Electrode Location After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease.

Effects of Pneumocephalus on Electrode Location After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease.

Journal: World neurosurgery

Published: March 04, 2025

Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic Activity.

Structure-Based Discovery of a Highly Selective, Oral Polo-Like Kinase 1 Inhibitor with Potent Antileukemic Activity.

Journal: Journal of medicinal chemistry

Published: February 18, 2025

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axis.

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axis.

Journal: Molecular biomedicine

Published: July 20, 2024

Progress with polo-like kinase (PLK) inhibitors: a patent review (2018-present).

Progress with polo-like kinase (PLK) inhibitors: a patent review (2018-present).

Journal: Expert opinion on therapeutic patents

Published: July 12, 2024

Radiotherapy Resistance of 3D Bioprinted Glioma via ITGA2/p-AKT Signaling Pathway.

Radiotherapy Resistance of 3D Bioprinted Glioma via ITGA2/p-AKT Signaling Pathway.

Journal: Advanced healthcare materials

Published: October 06, 2023

A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomas.

A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomas.

Journal: Heliyon

Published: September 27, 2023

Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration.

Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration.

Journal: Heliyon

Published: May 31, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026